Replies to post #32122 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

As long as IPCI can make some progress on the oral/nasal studies on their Oxy NDA candidate and make some headway on PODRAS studies, those 2 potential catalysts in their pipeline should be enough to revitalize interest in this stock as long as mgmt. begins updating the market on their status.

And if the FDA continues to not approve Pristiq or Lamictal and Mallinkrodt continues to not grow SeroquelXR sales, there will most certainly be a real fear of another offering necessary thus more pain ahead.

So I really hope some good news starts flowing soon and IPCI mgmt. is able to avoid a reverse split.

Regardless, I'm gonna ride this one into November with fingers crossed that the next 4 years will more than make up for the disappointments of the past 4 years similar to how things played out for that stock in the example you just provided Angelo.